Target- |
Mechanism- |
|
Originator Org.- |
|
Inactive Indication- |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
Target- |
Mechanism- |
|
|
|
Inactive Indication- |
Drug Highest PhasePhase 2 |
First Approval Ctry. / Loc.- |
First Approval Date- |
随机双盲、安慰剂平行对照评价妇春颗粒治疗女性更年期综合征肾阴阳两虚证有效性和安全和多中心Ⅱ期临床研究
[Translation] A randomized double-blind, placebo-controlled, parallel-controlled multicenter phase II clinical study to evaluate the efficacy and safety of Fuchun Granules in the treatment of kidney yin and yang deficiency syndrome in women with menopausal syndrome
初步评价妇春颗粒对更年期综合征症状群的治疗作用、对肾阴阳两虚证候及相关症状的改善作用,以及安全性观察。
[Translation] To preliminarily evaluate the therapeutic effect of Fuchun Granule on the symptom cluster of menopausal syndrome, its improvement effect on the syndrome of kidney yin and yang deficiency and related symptoms, and its safety observation.
调脂清肝胶囊治疗非酒精性单纯性脂肪肝痰浊阻遏证评价有效性安全性随机安慰剂平行对照多中心Ⅱ期临床研究
[Translation] A randomized, placebo-controlled, multicenter phase II clinical study evaluating the efficacy and safety of Tiaozhiqinggan Capsule in the treatment of nonalcoholic simple fatty liver with phlegm-turbidity inhibition syndrome
初步评价清肝调脂胶囊治疗非酒精性单纯性脂肪肝痰浊阻遏证的有效性和安全性。
[Translation] To preliminarily evaluate the efficacy and safety of Qinggan Tiaozhi Capsule in the treatment of non-alcoholic simple fatty liver with phlegm and turbidity obstruction syndrome.
100 Clinical Results associated with Jilin Beiyao Medicine Pharmaceutical Co., Ltd.
0 Patents (Medical) associated with Jilin Beiyao Medicine Pharmaceutical Co., Ltd.
100 Deals associated with Jilin Beiyao Medicine Pharmaceutical Co., Ltd.
100 Translational Medicine associated with Jilin Beiyao Medicine Pharmaceutical Co., Ltd.